Form 4 Filing for Axsome Therapeutics, Inc.

Susan Mahony, a director at Axsome Therapeutics, Inc. (AXSM), acquired 1,721 Restricted Stock Units (RSUs) on June 5, 2026. The RSUs were granted with a transaction value of $0 and represent a contingent right to receive one share of the Issuer's common stock. These RSUs vest in full on the one-year anniversary of the grant date. The transaction was reported on Form 4, with Susan Mahony having a direct ownership nature in the acquired securities. The post-transaction number of shares owned is 1,721.